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Abstract 
Background: In 2004, Ghana implemented the artemisinin‑based combination therapy (ACT) policy. Health worker 
(HW) adherence to the national malaria guidelines on case‑management with ACT for children below 5 years of age 
and older patients presenting at health facilities (HF) for primary illness consultations was evaluated 5 years post‑ACT 
policy change.
Methods: Cross‑sectional surveys were conducted from 2010 to 2011 at HFs that provide curative care as part of 
outpatient activities in two districts located in the middle belt of Ghana to coincide with the periods of low and high 
malaria transmission seasons. A review of patient medical records, HW interviews, HF inventories and finger‑pricked 
blood obtained for independent malaria microscopy were used to assess HW practices on malaria case‑management.
Results: Data from 130 HW interviews, 769 patient medical records at 20 HFs over 75 survey days were individually 
linked and evaluated. The majority of consultations were performed at health centres/clinics (68.3 %) by medical assis‑
tants (28.6 %) and nurse aids (23.5 %). About 68.4 % of HWs had received ACT‑specific training and 51.9 %, supervisory 
visits in the preceding 6 months. Despite the availability of malaria diagnostic test at most HFs (94 %), only 39.8 % 
(241) out of 605 (78.7 %) patients who reported fever were investigated for malaria. Treatment with ACT in line with 
the guidelines was 66.7 %; higher in <5 children compared to patients ≥5 years old. Judged against reference micros‑
copy, only 44.8 % (107/239) of ACT prescriptions that conformed to the guidelines were “truly malaria”. Multivariate 
logistic regression analysis showed that HW were significantly more likely to comply with the guidelines if treatment 
were by low cadre of health staff, were for children below 5 years of age, and malaria test was performed.
Conclusion: Although the majority of patients presenting with malaria received treatment according to the national 
malaria guidelines, there were widespread inappropriate treatment with ACT. Compliance with the guidelines on ACT 
use was low, 5 years post‑ACT policy change. The Ghana NMCP needs to strengthen HW capacity on malaria case‑
management through regular training supported by effective laboratory quality control measures.
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Background
Significant progress has been made in the last decade 
towards achieving global malaria targets although the 
disease burden is still relatively high in sub-Saharan Afri-
can countries, especially among children <5 years of age 
[1, 2]. According to a recent report by the World Health 
Organization (WHO), malaria accounted for approxi-
mately 1800 admissions and 10 deaths for every 100,000 
population in Ghana [2].
Prompt and effective malaria case management has 
been the main control strategy [3, 4]. Ghana implemented 
the artemisinin-based combination therapy (ACT) policy 
in 2004 with artesunate–amodiaquine as the first-line 
drug to replace chloroquine which is no more effective 
due to widespread development of Plasmodium resist-
ance across Africa [5]. The anti-malarial drug policy of 
ACT was revised in 2009 to include artemether–lume-
fantrine and dihydroartemisinin–piperaquine as alter-
native first-line treatment drugs due to poor tolerability 
of artesunate–amodiaquine by sections of the Ghana-
ian community [6]. The successful implementation of an 
ACT policy to a large extent depends on the availability 
of the ACT drugs and the ability of health professionals 
to adhere to national malaria treatment guidelines [7, 
8]. The introduction of Affordable Medicine Facility for 
Malaria (AMFm) to subsidize ACT, has expanded access 
to ACT and gave hope to endemic countries that piloted 
the scheme [9, 10].
Ghana revised her national guidelines for malaria case 
management to address changes in the anti-malarial drug 
policy [11]. The policy recommends parasitological diag-
nosis (using malaria rapid diagnostic test or microscopic 
examination of malaria blood smear) of all suspected 
cases prior to treatment with ACT. Specifically, the policy 
allowed presumptive diagnoses and treatment for malaria 
for children below 5 years due to operational considera-
tions and the fact that Ghana is a high malaria risk area 
[12]; but with a long-term goal of deploying a test, treat 
and track policy of all suspected cases. Treatment with 
ACT is recommended for positive test results for all chil-
dren and adults except for pregnant women in the first 
trimester who are required to use quinine.
Restricting treatment to parasitological diagnosis of 
malaria among older children and adults is expected to 
reduce over-diagnosis of malaria and inappropriate use 
of relatively expensive ACT in the treatment of fevers 
[13]. Proper clinical interpretation based on test results 
remains the main challenge in a change process after 
many years of believing that presence of fever denotes 
malaria [14].
In this study, the quality of uncomplicated malaria case 
management for children <5 years and older patients pre-
senting for primary illness consultation was assessed at 
health facilities (HFs) in two districts of the middle belt of 
Ghana 5 years post-ACT policy implementation by eval-
uating health worker (HW) compliance to the national 
malaria guidelines on ACT prescriptions.
Methods
Study area
The study was conducted in Kintampo North and South 
Districts, which lie within the forest savannah transi-
tional ecological zone in the middle belt of Ghana. The 
Kintampo districts cover an area of 7162 km2 and has a 
resident population of 134,970 as at 2009 [15]. Subsist-
ent farming is the main economic activity. Mean monthly 
temperature ranges between 18 and 38  °C with average 
rainfall of 1250 mm per annum. In children below 5 years 
of age, the incidence of malaria annually is seven episodes 
per child per year [16]. Malaria transmission is high 
(entomological inoculation rate: 269 infective bites per 
person per year) throughout the year but peaks between 
May and October and dips between December and April 
[17]. Like in other parts of Ghana, majority of malaria 
cases are diagnosed and treated at the community and/
or the primary health facility levels [11]. Licensed chemi-
cal shops are the first point of care for many illnesses 
including malaria [18]. There are two district hospitals 
that serve as patient referral points, 12 health centres/
clinics and 30 community-based health planning ser-
vices (CHPS) compounds. At the hospitals and private 
clinics, parasitiological diagnosis of malaria are often by 
malaria microscopy whilst malaria RDT kits are used at 
the peripheral HFs.
Study design
The design was a cross-sectional HF survey involving 
review of patient medical records, HW interviews, HF 
inventory and independent blood slide reading by a refer-
ence laboratory to assess provider compliance to malaria 
case-management based on the Ghana national malaria 
treatment guidelines.
Sample size calculation for health facility survey
In a controlled trial carried out in southern Ghana com-
pliance to malaria management with ACT based on 
malaria RDT and blood slide was 60.1 and 57.1 %, respec-
tively [19]. Seven hundred and twenty patients present-
ing for primary illness consultation were required to be 
sampled from at least 31 clusters with an intra-class cor-
relation 0.2 to be able to detect an assumed lesser com-
pliance of ≤53 % in this non-controlled study with 95 % 
confidence and with 90 % statistical power. A cluster was 
defined as all patient consultations performed at a HF on 
1 day during regular working hours from 8 am to 5 pm. A 
primary illness consultation was defined as the first time 
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a patient visited the HF for the treatment of the present-
ing illness episode.
Health facility surveys
Three cross-sectional cluster surveys each lasting 
5–8  weeks were conducted in January 2010, June 2010 
and in January 2011 at HFs that provide curative care as 
part of outpatient activities. These surveys were planned 
to coincide with the periods of low (January 2010 and 
January 2011) and high malaria transmission seasons 
(June 2010). Data collection was undertaken by a team 
comprising of a clinician, a laboratory technician and 
field data collectors under the supervision of the study 
investigators.
Selection
A list of 19 HFs in the study area that provided cura-
tive care as part of an out-patient setting during regular 
working hours from 8 am to 5 pm was used as the sam-
pling frame. The HFs in the sampling frame increased to 
20 with the establishment of an additional HF before the 
commencement of the second survey. Using a written 
programme in STATA, the HFs were randomly ordered 
and numbered consecutively. The HFs were assigned 
to pre-determined survey dates and visited in the same 
order and date as pre-determined. No other facility was 
visited on a survey day when the scheduled facility was 
found closed. HFs closed on the date of the survey were 
visited during a “catch-up period” on the same day of the 
week as originally determined. Dates of visits were not 
announced in advance to HF staff. On arrival at each HF, 
all HWs performing patient consultations were assigned 
identification numbers. Using a structured questionnaire, 
HWs were interviewed on their most recent ACT specific 
training, supervisory visits received and knowledge of the 
national malaria treatment guidelines. An inventory of 
diagnostic test kits, ACT and other medications available 
at the HF was made before patient consultations began.
Enrolment
On a survey day, all patients at the HF who met the inclu-
sion criteria of seeking primary consultation for their 
illness were asked to provide informed consent for par-
ticipating in the study. After receiving treatment, patients 
who had given an informed written consent had their 
weight and axillary temperature re-assessed using stand-
ardized equipment by the survey team. Patient demo-
graphics, vital signs, medical records and insecticide 
treated net (ITN) use were recorded on a standardized 
questionnaire. About 0.5 µl of whole blood was collected 
into EDTA (ethylenediaminetetraacetic acid) tubes and 
stored in a cool box and transferred to the reference 
laboratory for malaria microscopy. A review of patient 
medical records was performed by the team leader to 
extract medical information of the care patient received 
on the survey day. Information extracted from the patient 
folders included HWs’ record of patient medical history, 
presenting symptoms, diagnosis and treatment.
Blood sample processing at the reference laboratory
Thick and thin malaria films were prepared from blood 
collected and stained with Giemsa using the method rec-
ommended by WHO for blood smear preparation. The 
malaria blood smears were read independently by two 
experienced microscopists. In cases where the results 
were discrepant, a third microscopist read the slide for 
concordence with one of the two earlier readers. Assum-
ing a count of 8000 leukocytes/dl of blood, parasite den-
sities were calculated by counting the number of asexual 
parasites per 200 white blood cells [20]. A blood smear 
was considered negative if no parasite was found after 
counting 200 high power fields.
Data management and statistical analysis
All data forms were checked manually for completeness 
and consistencies before data processing. Epi info ver-
sion 7 software package was used for double entry, vali-
dation and verification of all data. Analysis was carried 
out using STATA, version 11 (StataCorp, College Station, 
TX, USA). The quality of outpatient malaria case man-
agement for each patient was evaluated by individually 
linking patient data (extracted medical information and 
reference malaria blood slide results) to the information 
of the HW and HF where patient received care on the 
survey day. The availability or absence of diagnostic test 
kits, medicines and ACT-specific training on the quality 
of care was further assessed.
The primary outcome for assessment was provider 
compliance based on the case management guidelines of 
the Ghana NMCP otherwise referred to as appropriate 
ACT treatment [11]. For all age groups, provider compli-
ance was defined as the proportion of patients presenting 
at a HF for primary illness consultation with or without 
fever but in the absence of any sign of severe malaria 
who were prescribed ACT on a positive test for malaria 
parasites or had an ACT withheld when a test for malaria 
parasite was negative. Among patients aged <5  years 
however, a diagnosis of malaria based on confirmatory 
testing was not required. A patient was considered to 
have fever if he/she had a record of fever within the pre-
vious 48 h and/or axillary temperature ≥37.5 °C.
A comparative analysis of HW routine use and inter-
pretation of malaria diagnostic test for <5 children and 
older patients with respect to a presentation of fever and 
ACT prescriptions was performed. The sensitivity, speci-
ficity as well as positive and negative predictive values 
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(NPV) of routine diagnostic tests relative to the reference 
microscopy were determined.
Univariate analysis was used to identify predictors of 
provider compliance to the national malaria treatment 
guidelines. Seasonality of malaria transmission and other 
explanatory variables such as age of patient, mode of 
diagnosis, type and level of HF, HW cadre and training 
on IMCI that showed a tendency of association with pro-
vider compliance were included in the multivariate logis-
tic regression. Data was summarized as frequencies and 
proportions with corresponding 95 % confidence interval 
adjusted for clustering by HF.
Ethical consideration
Ethical approval was provided by the Ghana Health Ser-
vice Ethics Review Committee (GHS-ERC) and Kintampo 
Health Research Centre Institutional Ethics Committee 
(KHRC-IEC). Permission to conduct the HF surveys were 
obtained from the local health administrations. Informed 
written consent was obtained from patients and care-
takers of children who were willing to participate in the 
study. Children aged 12–17  years of age were requested 
to provide their assent in addition to consent by par-
ent or accompanying adult without which a patient was 
excluded from the study. Unaccompanied minors were 
excluded as per regulations of the KHRC-IEC. Informed 
written consent were also obtained from HWs who per-
formed patient consultation on the day of survey. To 
maintain confidentiality, a unique study number/code was 
assigned to each participant as an identifier at enrolment 
for labelling all blood samples and study forms. All study 
data were stored securely with restricted access.
Results
Description of the sample population
Overall, 843 patient folder reviews and 132 HW inter-
views were performed at 20 HFs through 83 HF visits 
during three cross-sectional surveys (Fig. 1). In the first 
survey, 19 HFs were each visited once during which 143 
patient folder reviews and 42 HW interviews were con-
ducted. The second survey involved visits to 20 HFs 
during which 243 patient folder reviews and 44 HW 
interviews were performed. During both surveys, one HF 
that was closed on the survey day was still not opened 
during the “catch-up period”. To increase patient enrol-
ment during the third survey, each of the 20 HFs was vis-
ited twice during which 457 folder reviews and 46 HW 
interviews were performed. Two HFs that were closed on 
the first visit were available for study activities during the 
“catch-up period”.
Data from eight HF visits were excluded because they 
were closed (6) or had incomplete inventories (2) on 
the day of the visit. Seventy-four patient records were 
excluded from the analysis. Those excluded comprised 
of 18 patients who were on follow-up visits for previ-
ous illness and 36 pregnant women on the basis that the 
national guidelines does not recommend ACT treatment 
for pregnant women in the first trimester and the team 
did not plan for gestational assessment as part of this 
study. Others were 12 patients who did not consent to 
blood draw and 8 patients seen by two HWs whose inter-
views were incomplete. Analysis was, therefore, carried 
out on 769 patients’ data individually linked with each of 
the 130 HWs and 75 facility information of where patient 
received care on each survey day.
Background patient consultation by facility and health 
worker
The proportion of children <5 years of age presenting for 
a primary illness consultation was higher during the high 
malaria transmission season (HMTS) (33.8 %) than the low 
malaria transmission season (LMTS) (26.1  %) (Table  1). 
Insecticide-treated nets (ITNs) use the night before the 
survey was 34 % in the low LMTS and 51.4 % in the HMTS. 
The prevalence of fever was 70.7 % in the LMTS and 100 % 
in the HMTS. The seasonal difference in fever prevalence 
was statistically significant (p < 0.001) (Table 1).
A majority of patients (68.3 %; 525/769) were seen at the 
health centres/clinics (Table 2). Most patients were seen 
by medical assistants (28.6  %) and nurse aids or lower 
cadres (23.5 %) while medical doctors performed 18.7 % 
of patient consultations in both seasons (Table  2). HWs 
trained on the malaria treatment guidelines were 68.4 and 
51.9  % had received supervisory visits in the 6  months 
preceding survey. Functioning thermometer and weigh-
ing scales, diagnostic tools (microscopy or RDT) and at 
least any one of the recommended ACT were frequently 
available at the HFs during patient consultations (Table 2). 
However, only 45.1  % of patients were seen in consult-
ing rooms where the revised ACT or the national malaria 
treatment guidelines was available (Table 2).
Evaluating health worker practices against the national 
malaria treatment guidelines
Figure 2 shows HW routine practice on the use and inter-
pretation of diagnostic test results with respect to the 
presentations of fever and ACT prescription. The pro-
portion of patients presenting for primary illness con-
sultation without signs of severe malaria who reported 
a history of fever or an axillary temperature ≥37.5  °C 
was 78.7 % (605/769), higher among <5 children (89.4 %; 
194/217) than older patients (74.5 %; 411/552).
Use and interpretation of malaria diagnostic test
Overall, only 39.8  % (241/605) of patients who pre-
sented with fever had a malaria diagnostic test (RDT or 
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microscopy) performed; 47.9 % in children <5 and 36.0 % 
in patients ≥5  years. Of patients with fever who had a 
malaria test performed, 70.2  % (167/238) had malaria 
positive results more commonly in <5 children (82.4 %) 
than older patients (62.6 %). Among the 164 patients who 
had no report of fever, 52 (31.7 %) had a malaria test per-
formed of which 45.1 % (23/52) were positive; marginally 
higher in children <5 years (50 versus 44.2 %).
Prescription of ACT
The prescription of ACT for patients who had fever and 
malaria parasite was high (94  %; 157/167), 93.3  % in 
children <5  years and 94.6  % in patients ≥5  years. Fur-
thermore, presumptive treatment with ACT for febrile 
children <5 years was very high (81 %; 82/101). Contrary 
to treatment recommendation, 159 (60.5  %) of patients 
≥5 years who presented with fever were prescribed ACT 
without a malaria test performed.
Among 164 patients presenting with no fever, 31.7  % 
(52/164) were tested. Of these, 45.1 % (23/52) were posi-
tive and 91.3  % (21/23) were treated. No treatment was 
given to those found negative.
Total health worker 
(HW) interviews 
N = 132 
Total patient 
records reviewed  
N = 843 
Total health facility 
(HF) visits 
N = 83 
Patient on follow up 
visit excluded 
n = 18 
Incomplete HW 
interviews excluded 
n = 2 
HFs closed on  
survey days excluded 
(n=6) Pregnant women 
excluded 
n = 36
Patients refused blood 
draw excluded 
n = 12 
Patients seen by HWs 
with incomplete data 
excluded, n = 8 
Patients’ data  
linked for analysis 
n = 769 
HW interviews linked 
for analysis 
n = 130 
HF data linked  
for analysis 
n = 75 
HFs with incomplete 
inventories excluded 
(n=2) 
Fig. 1 Description of sample population and data analyzed
Table 1 Characteristics of  patient presenting for  initial 
consultations during  the low and  high malaria transmis-
sion seasons. N = 769
ITN insecticide-treated net, NHIS National Health Insurance Scheme
Characteristics Low season
N = 559
n (%)
High season
N = 210
n (%)
Both seasons 
N = 769
n (%)
Median age in years (range)
 <5 year olds 146 (26.1) 71 (33.8) 217 (28.2)
 ≥5 year olds 413 (73.9) 139 (66.2) 552 (71.8)
 Female 349 (62.4) 117 (55.7) 466 (60.6)
 Used ITN the  
previous night
190 (34.0) 108 (51.4) 298 (38.8)
 NHIS insured 509 (91.1) 186 (88.6) 695 (90.4)
 Fever prevalence 395 (70.7) 210 (100.0) 605 (78.7)
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Measuring provider compliance
In computing the primary outcome, 16 children 
<5  years who presented with fever but had a nega-
tive malaria test were excluded. This was done to pre-
vent judging as incorrect HW practice of prescribing 
ACT for <5 children who had a negative malaria test 
as the national treatment guidelines states that in <5 
children, fever or a history of fever in the absence of 
other causes of fever should be considered malaria and 
treatment commenced immediately without waiting 
for laboratory results. Three febrile children whose 
malaria test were not documented were also excluded.
Of the 750 patients presenting at HFs for primary ill-
ness consultation, 66.7  % were treated in accordance 
with the national malaria treatment guidelines; 239 
received ACT whilst ACT were appropriately withheld 
in 261 patients. About 89.2  % (239/268) of <5 children 
presenting with at least fever and patients ≥5 years with 
uncomplicated malaria were correctly treated with ACT. 
ACT correctly withheld in both <5 children who had no 
Table 2 Background health facility and  health worker characteristics of  patient consultations during  the low and  high 
malaria transmission seasons. N = 769
N = 769
CHPS community health planning services, CHN community health nurses, IMCI integrated management of childhood illness
Characteristics Low season
N = 559
n (%)
High season
N = 210
n (%)
Both seasons 
N = 769
n (%)
Health facility characteristics
 Type of facility
  Hospital 117 (20.9) 37 (17.6) 154 (20.0)
  Health centre/clinic 379 (67.8) 146 (69.5) 525 (68.3)
  CHPS 63 (11.3) 27 (12.9) 90 (11.7)
 Functional equipment
  Weight scale for all ages 13 (2.3) 66 (31.4) 79 (10.3)
  At least one weight scale 559 (100.0) 210 (100.0) 769 (100.0)
  Thermometer 555 (99.3) 210 (100.0) 765 (99.5)
 Wall charts/reference material
  Wall flowchart 494 (88.4) 172 (81.9) 666 (86.6)
  Revised malaria treatment guidelines 250 (44.7) 97 (46.2) 347 (45.1)
 Diagnostic testing available
  Microscopy 344 (61.5) 113 (53.8) 457 (59.4)
  Rapid diagnostic testing 348 (62.3) 170 (81.0) 518 (67.4)
  Either microscopy or RDT 520 (93.0) 203 (96.7) 723 (94.0)
 Anti‑malarial stock
  Artesunate amodiaquine 486 (86.9) 210 (100.0) 696 (90.5)
  Artemether lumefantrine 465 (83.2) 173 (82.4) 638 (83.0)
  Dihydroartemisinin piperaquine 97 (17.4) 0 97 (12.6)
  At least an ACT 559 (100.0) 210 (100.0) 769 (100.0)
Health worker characteristics
 Cadre consulting
  Medical doctor 102 (18.3) 42 (20.0) 144 (18.7)
  Medical assistant 178 (31.8) 42 (20.0) 220 (28.6)
  Midwife 47 (8.4) 15 (7.1) 62 (8.1)
  Trained nurse 47 (8.4) 30 (14.3) 77 (10.0)
  CHN 62 (11.1) 23 (11.0) 85 (11.1)
  Nurse aid or lower 123 (22.0) 58 (27.6) 181 (23.5)
 Training
  ACT‑specific 383 (68.5) 151 (71.9) 534 (68.4)
  IMCI 135 (24.5) 29 (13.8) 164 (21.3)
 Supervision within previous 6 months 289 (51.7) 110 (52.4) 399 (51.9)
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fever and older patients who had no routine diagnosis 
of uncomplicated malaria was 54.2 % (261/482). Judged 
against results from the reference microscopy, however, 
only 44.8  % (107/239) of routinely prescribed ACT that 
conformed to the malaria guidelines were “truly malaria”. 
On the other hand, 8 % (21/261) of patients missed the 
opportunity to receive ACT during routine care due to 
either false negative results.
The diagnostic accuracy of routine testing
The accuracy of the routine diagnostic tests namely 
malaria RDT and microscopy was determined with ref-
erence to expert microscopy (Table 3). The sensitivity of 
RDTs and microscopy were 67.4 and 34.2 % respectively. 
The specificities of routine diagnostics were high >95 % 
(RDT, 98.3 % and microscopy, 96.0 %). The positive pre-
dictive value (PPV) was high >97.5  % for both routine 
RDT and microscopy whilst the negative predictive value 
(NPV) was very low for routine microscopy (23.3 %) and 
relatively higher for RDT (66.7 %).
Factors associated with health worker compliance 
to treatment guidelines
When univariate analysis was carried out, HW compli-
ance in public HFs was found to be 66  % higher com-
pared to private HFs. CHPS were 92  % more likely to 
conform to treatment guidelines compared to hospitals. 
Compared to medical doctors, less qualified HWs such 
Given ACT 
All = 157 (94.0%)  
< 5= 70 (93.3%) 
%)
Given ACT 
All = 0 
< 5= 0 
Given ACT 
All = 21 (91.3%)  
< 5= 3 (75.0%) 
%)
Given ACT 
All = 28 (25.0%)  
< 5= 1 (6.7%) 
%)
Given ACT 
All = 241 (66.2%)  
< 5= 82 (81.2%) 
%)
Given ACT 
All = 12 (16.9%)  
< 5 = 0 
%)
Test negative 
All = 28(54.9%)  
< 5= 4 (50.0%) 
%)
Test positive 
All = 23(45.1%)  
< 5= 4 (50.0%) 
Test negative 
All =71(29.8%)  
< 5= 16(17.6%) 
%)
Test positive 
All =167(70.2%)  
< 5= 75(82.4%) 
Test done 
All = 52(31.7%)  
< 5=8 (34.8%) 
44(31.2%)
Test not done 
All =112(68.3%)  
< 5= 15(65.2%) 
97(68.8%)
Test not done 
All =364 (60.2%)  
< 5= 101(52.1%) 
263 (64.0%)
Test done 
All = 241(39.8%)  
 < 5=93(47.9%) 
148 (36.0%)
Had no fever 
All = 164(21.3%)  
< 5=23 (10.6%) 
%)
Had fever 
All = 605(78.7%)  
< 5= 194(89.4%) 
411(74.5%)
Outpatient 
consultations 
All =769(100.0%)  
< 5=217(28.2%) 
%)
Fig. 2 Health worker routine use and interpretation of malaria diagnostic test for <5 children and older patients with respect to a presentation 
of fever and ACT prescriptions. HW compliance to the national malaria treatment guideline for all patients was 66.7 %; 85.9 % in <5 children and 
59.7 % in older patients
Table 3 The diagnostic accuracy of  routine testing com-
pared with expert microscopy
Prevalence Rapid diagnostic test Microscopy
n/N (%; 95 % CI) n/N (%; 95 % CI)
Sensitivity 60/89 (67.4; 56.7–77.0) 41/120 (34.2; 25.8–43.4)
Specificity 58/59 (98.3; 90.9–100.0) 24/25 (96.0; 79.6–99.9)
Positive predictive  
value
60/61 (98.4; 91.2 –100.0) 41/42 (97.6; 87.4–99.9)
Negative predictive 
value
58/87 (66.7; 55.7–76.4) 24/103 (23.3;15.5–32.7)
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as midwives, community health nurse (CHN) and nurse 
aids were 4.74 times (OR  =  4.74, 95  % CI 2.10–10.72); 
3.17 times (OR = 3.17, 95 % CI 1.65–6.10) and 1.69 times 
(OR = 1.69, 95 % CI 1.07–2.69) more likely to conform to 
treatment guidelines.
Results of the multivariate logistic regression shows 
that mode of diagnosis for patients, age group and the 
cadre of HW were significantly associated with HW 
compliance to the national malaria treatment guidelines 
(Table 4). A clinical decision based on presumptive diag-
nosis to prescribe or withhold ACT to a patient suspected 
with malaria on a presentation of fever in the absence of 
any signs of severe malaria was 69 % (OR = 0.31, 95 % CI 
0.15–0.62) less likely to conform to the guidelines com-
pared to one that was based on parasitological diagnosis. 
HW management of children <5 years were significantly 
over four times (OR  =  4.49, 95  % CI 2.85–7.08) more 
likely to conform to the treatment guidelines compared 
to patients ≥5 years. The likelihood of less qualified HWs 
adhering better to the guidelines were demonstrated by 
community health nurse and midwives respectively 2.95 
times (OR  =  2.95, 95  % CI 1.37–6.38) and 4.87 times 
(OR = 4.87, 95 % CI 1.99–11.08) at higher odds of com-
plying with the guidelines compared to medical doctors. 
The differences were statistically significant.
Discussion
In this study, 66.7 % of patients presenting at HFs for pri-
mary illness consultation received treatment that was in 
line with the 2009 national malaria case-management 
guidelines 5  years after the deployment of the ACT 
policy in Ghana. Appropriate treatment with ACT was 
significantly higher in <5 children (85.9 %) than in older 
patients (59.7  %). The prescription of ACT based on a 
correct diagnosis of malaria as indicated by the national 
guidelines was high (89.2 %). However, 45 % of patients 
received ACT based on a wrong diagnosis of malaria. 
As a result of the low sensitivity of routine test, 8  % of 
patients who were confirmed by reference microscopy to 
have malaria missed the opportunity for any anti-malar-
ial treatment.
HWs non-compliance with the guidelines was a major 
cause of over-treatment with ACT. HW non-compliant 
behaviour observed in this study is similar to results from 
southern Ghana [19] and across many malaria endemic 
African countries namely Kenya [21], Angola [22], Zam-
bia [23], Benin [24] and The Gambia [25] after anti-
malarial policy change.
The lower compliance with ACT treatment based on 
presumptive diagnosis with its attendant over-treatment 
justifies the transition to new guidelines by the WHO 
requiring parasitological diagnosis of malaria univer-
sally regardless of age and malaria transmission levels 
(Table 4). Unfortunately, despite the universal availability 
of malaria diagnostic tools such as RDT and microscopy 
during patient consultations, they were often not used 
to guide treatment [26] neither were existing guidelines 
restricting ACT to only positive test in older patients 
complied with [27].
HW disregard to the existing guidelines raises questions 
about HW attitude and confidence in test results. For 
example, about 17 % of patients ≥5 years who presented 
with fever but had a negative test of malaria received 
ACT. Arguably, the unacceptably low sensitivity and NPV 
of routine diagnostics especially malaria microscopy com-
pared to the reference microscopy could possibly explain 
the mistrust and low use of diagnostic tools. A study 
conducted in Tanzania corroborates these observations 
[28]. The long held notion of equating fever as a proxy for 
malaria and the emphasis of malaria as a fatally dangerous 
disease have also contributed to the tendency for HWs to 
ignore test results [29]. As a result, a positive test result 
is often judged as a confirmation of their clinical judg-
ment and a negative test is still regarded as a suspected 
case of malaria rather than an absence of malaria. Such 
practices are likely to result in over-treatment with greater 
cost implications [30]. It is, however assuring that HWs 
belief in test results are likely to improve with confidence 
and trust gained through positive outcomes on appropri-
ate prescribing practice. Such change in practice has been 
observed in a study in Senegal where HW reliance on test 
results in clinical decision improve with time [31].
The management of <5 children was more likely to 
conform to the guidelines compared to older patients 
(Table  4). The high level of appropriate ACT treatment 
among <5 children is most likely attributable to their 
higher fever prevalence, and the tendency for HWs to 
resort to presumptive treatment with ACT perhaps due 
to practices over the years whereby presence of fever is 
indicative of malaria. This assertion is supported by the 
equal proportions of ACT prescribed for under-five chil-
dren and older patients presenting with fever who had a 
routine positive test of malaria (Fig. 2).
CHNs and midwives are low in the hierarchy of the HW 
professional ladder due to their limited scope of practice 
compared to medical officers. Their relatively huge pres-
ence seen in the management of most patients presenting 
for primary consultations notwithstanding their training 
on malaria case-management shows major task shifting, 
an indication of the shortage of medical doctors/medi-
cal assistants at the HFs in rural communities. The find-
ings that lower cadre of health staff adhered much more 
closely to the guidelines compared to medical doctors as 
found in studies conducted in Kenya and rural Tanza-
nia [8, 32] underscores task shifting as a tool to address 
shortage of human resource in the health system.
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Table 4 Factors associated with health worker compliance to treatment guideline. N = 750
N = 750
N/A non applicable
Factors n (%) complied Univariate logistic regression Multivariate logistic regression
OR 95 % CI p value OR 95 % CI p value
Malaria transmission season
 Low 65.81 1 1
 High 68.93 1.15 0.82–1.63 0.418 0.99 0.68–1.46 0.996
Mode of diagnosis
 Parasite based 67.61 1 1
 Presumptive 52.17 0.52 0.29–0.95 0.034 0.31 0.15–0.62 0.001
Age category of patient
 ≥5 years 59.71 1 1
 <5 years 85.93 4.12 2.67–6.36 0.000 4.49 2.85–7.08 0.000
Active member of the National Health Insurance Scheme
 Yes 65.68 1
 No 76.06 1.65 0.94–2.93 0.080 N/A N/A N/A
Type of health facility
 Private 59.87 1 1
 Public (MOH) 71.18 1.66 1.23–2.25 0.001 1.25 0.80–1.97 0.328
Level of health facility
 Hospital 65.13 1 1
 Health centre/clinic 65.17 1.00 0.68–1.46 0.994 0.66 0.37–1.16 0.148
 CHPS 78.16 1.92 1.04–3.52 0.036 0.99 0.45–2.19 0.976
Cadre of health worker
 Medical doctor 57.34 1 1
 Medical assistant 60.47 1.14 0.74–1.75 0.556 0.97 0.61–1.54 0.900
 Trained nurse 64.94 1.38 0.78–2.44 0.274 1.62 0.81–3.23 0.169
 Nurse aide or lower 69.49 1.69 1.07–2.69 0.025 1.61 0.88–2.94 0.124
 Community health nurse 81.01 3.17 1.65–6.10 0.001 2.95 1.37–6.38 0.006
 Midwife 86.44 4.74 2.10–10.72 0.000 4.87 1.99–11.08 0.001
Health worker received any ACT‑specific training
 Yes 67.82 1
 No 64.04 0.84 0.61–1.17 0.313 N/A N/A N/A
Availability of malaria diagnostic tools
 Yes 67.50 1
 No 61.68 0.77 0.51–1.18 0.238 N/A N/A N/A
Availability of wall flowchart in the consulting room
 Yes 66.10 1
 No 70.30 1.21 0.77–1.92 0.406 N/A N/A N/A
Availability of revised malaria treatment guidelines in the consulting room
 Yes 69.85 1
 No 64.10 0.77 0.57–1.05 0.097 N/A N/A N/A
Health worker attended any training on Integrated Management of Childhood Illness
 Yes 73.91 1 1
 No 64.69 0.65 0.44–0.96 0.028 0.66 0.42–1.05 0.079
Health worker had any supervisory visits within 6 months preceding the survey
 Yes 66.58 1
 No 66.76 1.01 0.74–1.37 0.959 N/A N/A N/A
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Results from this study also highlights the need for 
improved laboratory capacity at the primary care level 
for early and effective management of both malarial and 
non-malarial fevers. Under-diagnosis of malaria due to 
low sensitivity of routine diagnostics is a major concern 
with far-reaching clinical consequences. The “missed 
opportunity” for early treatment of malaria especially in 
children could result in severe malaria with high fatality 
outcome [12]. Likewise, the management of non-malaria 
febrile illnesses such as sepsis and meningitis require a 
comprehensive laboratory investigation to narrow down 
to the cause of fever for effective administration of anti-
biotic. In the absence of efficient laboratory capacity and 
proper interpretation of malaria test results based on the 
guidelines, HWs are likely to continue the wrong pre-
scription of anti-malarial or resort to the use of antibiot-
ics for managing non-malarial febrile illnesses [33, 34].
Limitations
The interpretation of findings from this study should 
be interpreted with caution as Hawthorne effect could 
play an important role considering the context in which 
data was collected; issues related to observer effects, i.e. 
a positive change in the behavior of HW resulting in a 
better than usual performance when observed or moni-
tored closely [35, 36]. This may provide some limitations 
on the study design. The presence of the study team at 
the facility before consultation may have influenced HWs 
performance beyond their usual levels, a further dem-
onstration of their non-compliant behaviour  when not 
observed in their usual practice. The effect may be mini-
mal as observed in other studies which had a member of 
the study team directly observing HW interactions with 
patient in the consulting room [37, 38].
Conclusion
Although a high proportion of <5 children presenting 
with fever and older patients with uncomplicated malaria 
received ACT in accordance with the national malaria 
guidelines, inappropriate treatment with ACT was still 
high especially among older patients five  years after 
anti-malarial policy change. This was due to poor inter-
pretation of the national malaria treatment guidelines 
particularly on malaria test result and low quality of rou-
tine malaria diagnostics.
Concerted effort towards improving rational use of 
ACT by HWs is urgently needed if the anticipated ben-
efits of the policy change are to be realized. The Ghana 
NMCP needs to strengthen the capacity of HWs through 
regular training [39] and supervision [40] on the malaria 
guidelines especially on treatment decisions made on the 
basis of a test result. The capacity of laboratories at the 
primary health care level needs to be enhanced through 
regular training for laboratory technicians and develop-
ment of effective quality control measures.
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